Yanshan Huang, PhD
Zhejiang Doer Biologics Co., Ltd.
3
0
1
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Junfang Xu, MD
Huadong Medicine Co., Ltd.
Shared therapeutic areas:
Worked with same sponsors:
Hongming Pan, MD,PhD
Sir Run Run Shaw Hospital
Shared therapeutic areas:
Worked with same sponsors:
Alexandra Cole, DHPharm
New Zealand Clinical Research (NZCR)
Shared therapeutic areas:
Worked with same sponsors:
Caicun Zhou, MD
Shanghai Pulmonary Hospital, Shanghai, China
Shared therapeutic areas:
Worked with same sponsors:
Yongliang Fang, PhD
Zhejiang Doer Biologics Co., Ltd.
Shared therapeutic areas:
Worked with same sponsors:
Yifan Zhai, MD, PhD
Ascentage Pharma Group Inc.
Shared therapeutic areas:
You Lu, MD
West China Hospital
Shared therapeutic areas:
Barbara Murphy, MD
Vanderbilt-Ingram Cancer Center
Shared therapeutic areas:
Staci M Peron, Ph.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Jianmin Fang, Ph.D
RemeGen Co., Ltd.
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors
A First in Human (FIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DR10624
A Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DR30303 in Patients With Advanced Solid Tumors
All 3 trials loaded